The paclitaxel acute pain syndrome: Sensitization of nociceptors as the putative mechanism

Cancer Journal

Volumn 13, Issue 6, 2007, Pages 399-403

  Loprinzi, Charles L ^a   Maddocks Christianson, Kami ^a   Wolf, Sherry L ^a   Rao, Ravi D ^a   Dyck, P James B ^a   Mantyh, Patrick ^b   Dyck, Peter J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Paclitaxel induced pain

Indexed keywords

PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG INDUCED DISEASE; ENDOMETRIUM CANCER; FEMALE; HIP PAIN; HUMAN; JOINT; LEG PAIN; LUNG CANCER; MALE; MUSCLE; MYALGIA; NERVE INJURY; NOCICEPTIVE RECEPTOR; OVARY CANCER; OVARY TERATOMA; PAIN; PATHOPHYSIOLOGY; PERITONEUM CANCER; PRIORITY JOURNAL; SENSITIZATION; SHOULDER; STRUCTURED INTERVIEW; SYMPTOM; THIGH; TONSIL CANCER; DRUG EFFECT; MIDDLE AGED; NEOPLASM; PHYSIOLOGY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NOCICEPTORS; PACLITAXEL; PAIN;

EID: 39749182862     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31815a999b     Document Type: Article

References (14)

1. Garrison JA, McCune JS, Livingston RB, et al. Myalgias and arthralgias associated with paclitaxel. Oncology. 2003;17:271-277; discussion 281- 282.
2. Rowinsky E, Eisenhauer E, Chaudhry V. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol. 1993;20(4 suppl 3):1-15.
3. Dyck PJ, Dyck PJB, Chalk CH. The 10 P's: a pneumonic for the characterization and differential diagnosis of peripheral neuropathy. Neurology. 1992;42:14-18.
4. Apfel SC, Asbury AK, Bril V, et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci. 2001;189:3-6.
5. Dyck PJ. The clinical heterogeneity of immune sensory and autonomic neuropathies with (or without) sicca. Brain. 2005;128:2480-2482.
6. Dyck PJ, Pertoutka S, Rask C, et al. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology. 1997;48:501-505.
7. Nguyen V, Lawrence H. Use of gabapentin in the prevention of taxaneinduced arthralgias and myalgias. J Clin Oncol. 2004;22:1767-1769.
8. New P, Jackson C, Rinaldi D, et al. Peripheral neuropathy secondary to docetaxel. Neurology. 1999;46:108-111.
9. Van Deventer H, Bernard S. Use of gabapentin to treat taxane-induced myalgias. J Clin Oncol. 1999;17:434-435.
10. Durand J, Goldwasser F. Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine case report. Anticancer Drugs. 2002;13:777-780.
11. Savares D, Boucher J, Corey B. Glutamine treatment of paclitaxel-induced myalgias and arthralgias. J Clin Oncol. 1998;16:3918-3919.
12. Jacobson S, Loprinzi C, Sloan J, et al. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol. 2003; 1:274-278.
13. Jimenez-Andrade JM, Peters CM, Mejia NA, et al. Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat. Neurosci Lett. 2006;405:62-67.
14. Peters CM, Jimeniz-Andrade JM, Jonas BM, et al. Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration an injury to sensory neurons and their supporting cells. Exp Neurol. 2007;203:42-54.